[1] Majeed S.K., Mast cell distribution in rats, Arzneimittelforschung, 1994, 44, 370–374 Google Scholar

[2] Melander A., Sundler F., Significance of thyroid mast cells in thyroid hormone secretion, Endocrinology, 1972, 90, 802–807 http://dx.doi.org/10.1210/endo-90-3-802CrossrefGoogle Scholar

[3] De Forteza R., Banovac K., Koren E., Effects of mast cell chymase on the morphology of thyroid cells in vitro, Int. Arch. Allergy Immunol., 1992, 99, 133–140 http://dx.doi.org/10.1159/000236347CrossrefGoogle Scholar

[4] Melander A., Westgren U., Sundler F., Ericson L.E., Influence of histamine- and 5-hydroxytryptaminecontaining thyroid mast cells on thyroid blood flow and permeability in the rat, Endocrinology, 1975, 97, 1130–1137 http://dx.doi.org/10.1210/endo-97-5-1130CrossrefGoogle Scholar

[5] Modlinger G., Circadian rhythm of the thyroid mast cells in untreated and methylthiouracil-treated rats, Folia Biol. (Krakow), 1989, 37, 155–164 Google Scholar

[6] Wynford-Thomas D., Stringer B.M., Mast cell hyperplasia during goitrogen-induced thyroid growth — a quantitative study, Acta Endocrinol. (Copenh), 1982, 101, 365–370 Google Scholar

[7] Toda S., Tokuda Y., Koike N., Yonemitsu N., Watanabe K., Koike K., et al., Growth factor-expressing mast cells accumulate at the thyroid tissue-regenerative site of subacute thyroiditis, Thyroid, 2000, 10, 381–386 http://dx.doi.org/10.1089/thy.2000.10.381CrossrefGoogle Scholar

[8] Melillo R.M., Guarino V., Avilla E., Galdiero M.R., Liotti F., Prevete N., et al., Mast cells have a protumorigenic role in human thyroid cancer, Oncogene, 2010, 29, 6203–6215 http://dx.doi.org/10.1038/onc.2010.348CrossrefGoogle Scholar

[9] US EPA, Atrazine interim reregistration eligibility decision, Environmental Protection Agency, Case No. 0062, 2003 Google Scholar

[10] WHO, Guidelines for drinking-water quality, 2nd ed., World Health Organization, Geneva, 1996 Google Scholar

[11] Foradori C.D., Hinds L.R., Hanneman W.H., Handa R.J., Effects of atrazine and its withdrawal on gonadotropin-releasing hormone neuroendocrine function in the adult female Wistar rat, Biol. Reprod., 2009, 81, 1099–1105 http://dx.doi.org/10.1095/biolreprod.109.077453CrossrefGoogle Scholar

[12] Fraites M.J., Cooper R.L., Buckalew A., Jayaraman S., Mills L., Laws S.C., Characterization of the hypothalamic-pituitary-adrenal axis response to atrazine and metabolites in the female rat, Toxicol. Sci., 2009, 112, 88–99 http://dx.doi.org/10.1093/toxsci/kfp194CrossrefGoogle Scholar

[13] Abarikwu S.O., Adesiyan A.C., Oyeloja T.O., Oyeyemi M.O., Farombi E.O., Changes in sperm characteristics and induction of oxidative stress in the testis and epididymis of experimental rats by a herbicide, atrazine, Arch. Environ. Contam. Toxicol., 2010, 58, 874–882 http://dx.doi.org/10.1007/s00244-009-9371-2CrossrefGoogle Scholar

[14] Stoker T.E., Laws S.C., Guidici D.L., Cooper R.L., The effect of atrazine on puberty in male Wistar rats: An evaluation in the protocol for the assessment of pubertal development and thyroid function, Toxicol. Sci., 2000, 58, 50–59 http://dx.doi.org/10.1093/toxsci/58.1.50CrossrefGoogle Scholar

[15] Rajkovic V., Matavulj M., Johansson O., Studies on the synergistic effects of extremely low-frequency magnetic fields and the endocrine-disrupting compound atrazine on the thyroid gland, Int. J. Radiat. Biol., 2010, 86, 1050–1060 http://dx.doi.org/10.3109/09553002.2010.501837CrossrefGoogle Scholar

[16] Weibel E.R., Stereological methods: vol 1, Practical methods for biological morphometry, Academic Press, New York, 1979 Google Scholar

[17] Clayton J.A., Masuoka D.T., TSH-induced mobilization of serotonin from perivascular mast cells in the rat thyroid, Endocrinology, 1968, 83, 263–271 http://dx.doi.org/10.1210/endo-83-2-263CrossrefGoogle Scholar

[18] Ericson L.E., Hakanson R., Melander A., Owman C., Sundler F., TSH-induced release of 5-hydroxytryptamine and histamine from rat thyroid mast cells, Endocrinology, 1972, 90, 795–801 http://dx.doi.org/10.1210/endo-90-3-795CrossrefGoogle Scholar

[19] Melander A., Owman C., Sundler F., TSH-induced appearance and stimulation of amine-containing mast cells in the mouse thyroid, Endocrinology, 1971, 89, 528–533 http://dx.doi.org/10.1210/endo-89-2-528CrossrefGoogle Scholar

[20] Mizota K., Ueda H., Endocrine disrupting chemical atrazine causes degranulation through Gq/11 protein-coupled neurosteroid receptor in mast cells, Toxicol. Sci., 2006, 90, 362–368 http://dx.doi.org/10.1093/toxsci/kfj087CrossrefGoogle Scholar

[21] Fakhouri W.D., Nunez J.L., Trail F., Atrazine binds to the growth hormone-releasing hormone receptor and affects growth hormone gene expression, Environ. Health Perspect., 2010, 118, 1400–1405 http://dx.doi.org/10.1289/ehp.0900738CrossrefGoogle Scholar

[22] Ringvall M., Ronnberg E., Wernersson S., Duelli A., Henningsson F., Abrink M., et al., Serotonin and histamine storage in mast cell secretory granules is dependent on serglycin proteoglycan, J. Allergy Clin. Immunol., 2008, 121, 1020–1026 http://dx.doi.org/10.1016/j.jaci.2007.11.031CrossrefGoogle Scholar

[23] Banerjee S.N., Dasgupta S.R., Age-related alteration of thyroidal and mesenteric mast cells of male albino rat, Exp. Gerontol., 1981, 16, 475–479 http://dx.doi.org/10.1016/0531-5565(81)90028-0CrossrefGoogle Scholar

[24] Kornilovskaya I.N., Gorelaya M.V., Usenko V.S., Gerbilsky L.V., Berezin V.A., Histological studies of atrazine toxicity on the thyroid gland in rats, Biomed. Environ. Sci., 1996, 9, 60–66 Google Scholar

[25] Maes M., Mommen K., Hendrickx D., Peeters D., D’Hondt P., Ranjan R., et al., Components of biological variation, including seasonality, in blood concentrations of TSH, TT3, FT4, PRL, cortisol and testosterone in healthy volunteers, Clin. Endocrinol., 1997, 46, 587–598 http://dx.doi.org/10.1046/j.1365-2265.1997.1881002.xCrossrefGoogle Scholar

[26] Frossi B., De Carli M., Daniel K.C., Rivera J., Pucillo C., Oxidative stress stimulates IL-4 and IL-6 production in mast cells by an APE/Ref-1-dependent pathway, Eur. J. Immunol., 2003, 33, 2168–2177 http://dx.doi.org/10.1002/eji.200323995Google Scholar

[27] Frossi B., Rivera J., Hirsch E., Pucillo C., Selective activation of Fyn/PI3K and p38 MAPK regulates IL-4 production in BMMC under nontoxic stress condition, J. Immunol., 2007, 178, 2549–2555 Google Scholar

[28] Chodaczek G., Bacsi A., Dharajiya N., Sur S., Hazra T.K., Boldogh I., Ragweed pollen-mediated IgE-independent release of biogenic amines from mast cells via induction of mitochondrial dysfunction, Mol. Immunol., 2009, 46, 2505–2514 http://dx.doi.org/10.1016/j.molimm.2009.05.023CrossrefGoogle Scholar

[29] Singh M., Sandhir R., Kiran R., Alterations in Ca2+ homeostasis in rat erythrocytes with atrazine treatment: positive modulation by vitamin E, Mol. Cell. Biochem., 2010, 340, 231–238 http://dx.doi.org/10.1007/s11010-010-0422-9Google Scholar

[30] Singh M., Kaur P., Sandhir R., Kiran R., Protective effects of vitamin E against atrazine-induced genotoxicity in rats, Mutat. Res., 2008, 654, 145–149 Google Scholar

[31] Bagchi D., Bagchi M., Hassoun E.A., Stohs S.J., In vitro and in vivo generation of reactive oxygen species, DNA damage and lactate dehydrogenase leakage by selected pesticides, Toxicology, 1995, 104, 129–140 http://dx.doi.org/10.1016/0300-483X(95)03156-ACrossrefGoogle Scholar

[32] Beane-Freeman E.L., Rusiecki A.J., Hoppin A.J., Lubin H.J., Koutros S., Andreotti G., et al., Atrazine and cancer incidence among pesticide applicators in the agricultural health study (1994–2007), Environ. Health Perspect., 2011, 119, 1253–1259 http://dx.doi.org/10.1289/ehp.1103561CrossrefGoogle Scholar